Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Adverse Late Effects"'
Autor:
Mona Omar, Sami El Khatib
Publikováno v:
Cancer and Oncology Research. 6:11-25
The high prevalence of malnutrition in adult and pediatric cancer patients has been appreciated for decades and continues to be documented. Although the prognostic significance of nutritional status among patients with cancer remains controversial, i
Autor:
Lenka Rossmeislová, Tomáš Kepák, Marcela Hortová Kohoutková, Teresa Zelante, Carmine Vacca, Rafal Marciniak, Kamila Bendíčková, Michaela Šiklová, Jan Fric, Zdenka Křenová, Petra Lázničková, Luděk Horváth, Kateřina Sheardová, Jaroslav Štěrba
Publikováno v:
European Journal of Immunology
Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8+ T cell compartment and elevated plasma TNF‐α but in later follow‐up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient r
Autor:
Daniel Cullen, Thi Nguyet Que Nguyen, Dinesh K. R. Medipally, Fiona M. Lyng, Ganesh D. Sockalingum, Jane Bryant, Marie Finn, Aidan D. Meade, Emma Noone, Aoife M. Shannon, Shirley Bradshaw, Mary Dunne, John Armstrong, Valérie Untereiner
Publikováno v:
Cancers
Cancers, MDPI, 2019, 11 (7), pp.925. ⟨10.3390/cancers11070925⟩
Cancers, Vol 11, Iss 7, p 925 (2019)
Volume 11
Issue 7
Cancers, MDPI, 2019, 11 (7), pp.925. ⟨10.3390/cancers11070925⟩
Cancers, Vol 11, Iss 7, p 925 (2019)
Volume 11
Issue 7
Radiation therapy (RT) is used to treat approximately 50% of all cancer patients. However, RT causes a wide range of adverse late effects that can affect a patient&rsquo
s quality of life. There are currently no predictive assays in clinical use
s quality of life. There are currently no predictive assays in clinical use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eed6dae0a605bf12185853b127f54171
https://hal.univ-reims.fr/hal-02310323
https://hal.univ-reims.fr/hal-02310323
Publikováno v:
European Journal of Oncology Nursing. 45:101728
Purpose In the UK, there are over 40,000 childhood cancer survivors (CCS); this figure grows approximately 1300 annually. Two-thirds are at risk of developing serious disabling or life-threatening conditions due to adverse late effects of the cancer
Publikováno v:
Pediatric hematology and oncology. 35(1)
In recent years, survival rates of childhood cancers have significantly increased, and occurrence of long-term adverse late effects (eg, insulin resistance, diabetes mellitus, metabolic syndrome, hypertension) has become increasingly important. Early
Publikováno v:
Cancers
The authors would like to make an addendum to their published paper [...]
Autor:
Torunn I. Yock, Paul A. Caruso
Publikováno v:
Health Physics. 103:577-585
Control rates for pediatric and adult malignancies are now approximately 80 and 60%, respectively, due to dramatic improvements in surgery, chemotherapy, and radiotherapy. However, radiotherapy is responsible for many of the adverse late effects of t
Autor:
Mary Lou Galantino, Kirsten K. Ness, Lisa VanHoose, G. Stephen Morris, Meredith Wampler, Laura Gilchrist, Victoria G. Marchese
Publikováno v:
Topics in Geriatric Rehabilitation. 27:234-243
Autor:
Guadalupe R. Palos, Patricia Chapman, Paula A. Lewis-Patterson, Weiqi Bi, Maria Alma Rodriguez, Katherine Ramsey Gilmore
Publikováno v:
Journal of Clinical Oncology. 36:26-26
26 Background: Research indicates survivors of head and neck cancers (HNC) are at greater risk for recurrences and adverse late effects. HNC survivorship algorithms are available to provide consistent and optimal care to this at-risk group. Here, we
Publikováno v:
European Journal of Cancer, 43(1), 122-130. ELSEVIER SCI LTD
Purpose 1. To assess health-related quality of life (HRQoL) of adult long term (up to 20 years) and very long term (>20 years) childhood cancer survivors, compared to the HRQoL of an age matched Dutch population sample. 2. To evaluate the impact of c